These will be used to package a medication indicated for the prophylaxis and treatment of seasonal and perennial allergic rhinitis, as well as vasomotor rhinitis.
University of Birmingham Enterprise announces the launch of Biocell Energetics, to provide profiling and testing services that assess, in real-time, how living cells produce energy.
ProductLife Group announced the acquisition of Halloran Consulting Group, uniting both companies under a commitment to provide safe and effective healthcare solutions across the globe.
Patients receiving treatment for bowel cancer at Sheffield Teaching Hospitals NHS Foundation Trust will have the chance to try personalised 'vaccines' thanks to the launch of a NHS “matchmaking” service.
Johnson & Johnson (J&J) has announced that it has taken over all sales, marketing, and distribution responsibilities for Remicade (infliximab) and Simponi (golimumab) in the UK.
Paul Shu of ARISTA Corporation, explains how pharma manufacturers are increasingly turning to wearable biometric ID products to securely speed authentication in a hands-free manner.
As part of the group's GreenUp strategic plan, Veolia Water Technologies is opening this centre to drive water treatment innovation, growth and training in Europe and beyond for the pharmaceutical, science and healthcare markets.
MGS is expanding its innovative Fast-Track Tooling Program, designed to accelerate product development timelines and reduce costs for pharmaceutical, diagnostic and medtech companies.
Yourgene Health announced that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene Cystic Fibrosis Base assay.